This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation.
Biology · 2026 · senior author
Investigating the Interactions of a Cyclic Peptide Hormone Somatostatin and Its Derivatives on Amyloid-Beta Aggregation.
ACS chemical neuroscience · 2025
Computational Mapping of Conformational Dynamics and Interaction Hotspots of Human VISTA with pH-Selective Antibodies.
Biochemistry · 2025 · senior author
Latest funding
- $148,000
Development of computational models to understand the dynamic molecular recognition mechanisms of cannabinoid receptors
NSERC · 2021 · Principal investigator
- $12,500
Development of computational models to understand the dynamic molecular recognition mechanisms of cannabinoid receptors
NSERC · 2021 · Principal investigator
- $250,000
An innovative approach designed to disrupt RNA binding protein aggregation and attenuate neurodegeneration in multiple sclerosis
SSHRC · 2020 · Co-investigator
14 publications.
Neuropharmacology of Nicotine Addiction and Therapeutic Strategies for Smoking Cessation.
Hefny AA, Karuturi RC, Kalyaanamoorthy S, Rao PPN, Ganesan A
Investigating the Interactions of a Cyclic Peptide Hormone Somatostatin and Its Derivatives on Amyloid-Beta Aggregation.
Pham AT, Zhao Y, Oo A, Hefny AA, Ganesan A, Rao PPN
Computational Mapping of Conformational Dynamics and Interaction Hotspots of Human VISTA with pH-Selective Antibodies.
Ly N, Ramgoolam SD, Ganesan A
Revealing the impact of active site residues in modeling the inhibition mechanism of SARS-Cov-2 main protease by GC373.
Aboelnga MM, Petgrave M, Kalyaanamoorthy S, Ganesan A
Deciphering the Molecular Association of Human CRIP1a with an Agonist-Bound Cannabinoid Receptor 1.
Petgrave M, Ramgoolam SD, Ganesan A
Post-Translational Modifications in Tau and Their Roles in Alzheimer's Pathology.
Kalyaanamoorthy S, Opare SK, Xu X, Ganesan A, Rao PPN
The H163A mutation unravels an oxidized conformation of the SARS-CoV-2 main protease.
Tran N, Dasari S, Barwell SAE, McLeod MJ, Kalyaanamoorthy S, Holyoak T, Ganesan A
Sequence- and structure-specific RNA oligonucleotide binding attenuates heterogeneous nuclear ribonucleoprotein A1 dysfunction.
Clarke JP, Thibault PA, Fatima S, Salapa HE, Kalyaanamoorthy S, Ganesan A, Levin MC
Design and Development of COX-II Inhibitors: Current Scenario and Future Perspective.
Chahal S, Rani P, Kiran, Sindhu J, Joshi G, Ganesan A, Kalyaanamoorthy S, Mayank, Kumar P, Singh R, Negi A
Structure-based virtual screening, molecular dynamics and binding affinity calculations of some potential phytocompounds against SARS-CoV-2.
Naik SR, Bharadwaj P, Dingelstad N, Kalyaanamoorthy S, Mandal SC, Ganesan A, Chattopadhyay D, Palit P
Development of computational models to understand the dynamic molecular recognition mechanisms of cannabinoid receptors
Principal investigators: Ganesan, Aravindhan
Keywords: computational modelling; cannabinoid receptors; small molecules; molecular dynamics; machine learning models; virtual screening; molecular mechanisms; gpcrs; competitive binding assays; receptor activation
Development of computational models to understand the dynamic molecular recognition mechanisms of cannabinoid receptors
Principal investigators: Ganesan, Aravindhan
An innovative approach designed to disrupt RNA binding protein aggregation and attenuate neurodegeneration in multiple sclerosis
Principal investigators: Levin, Michael
Keywords: multiple sclerosis neurodegeneration optogenetics bioinformatics computational modeling molecular dynamics peptide:protein dynamics hnRNP A1 RNA binding protein proteinopathy
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Aravindhan Ganesan and Subha Kalyaanamoorthy: 10 shared papers
- Khaled Barakat and Subha Kalyaanamoorthy: 2 shared papers
- Khaled Barakat and Aravindhan Ganesan: 1 shared paper
- Todd Holyoak and Aravindhan Ganesan: 1 shared paper
- Todd Holyoak and Subha Kalyaanamoorthy: 1 shared paper
- School of Pharmacy
- Chemistry
- Pharmacy and Pharmaceutical Science, Faculty of
- Biology
Co-authors at University of Waterloo, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.